Compounds > dobutamine
Page last updated: 2024-08-23

dobutamine and Hypertrophy, Right Ventricular

dobutamine has been researched along with Hypertrophy, Right Ventricular in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arheden, H; Carlsson, M; Heiberg, E; Ostenfeld, E; Steding-Ehrenborg, K; Stephensen, SS; Thilén, U1
Balestra, GM; Eerbeek, O; Mik, EG; Specht, PA; van der Laarse, WJ; Zuurbier, CJ1
Chesler, NC; Hacker, TA; Tabima, DM1
Akhter, SA; Archer, SL; Blaxall, BC; D'Souza, KM; Fang, YH; Parikh, KS; Paul, J; Piao, L; Pogoriler, J; Ryan, JJ; Theccanat, T; Toth, PT1

Other Studies

4 other study(ies) available for dobutamine and Hypertrophy, Right Ventricular

ArticleYear
Alterations in ventricular pumping in patients with atrial septal defect at rest, during dobutamine stress and after defect closure.
    Clinical physiology and functional imaging, 2018, Volume: 38, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atropine; Cardiac Catheterization; Cardiotonic Agents; Case-Control Studies; Child; Child, Preschool; Dobutamine; Female; Heart Septal Defects, Atrial; Humans; Hypertrophy, Right Ventricular; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Muscarinic Antagonists; Predictive Value of Tests; Recovery of Function; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Young Adult

2018
Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Respiratory research, 2015, Feb-03, Volume: 16

    Topics: Administration, Inhalation; Animals; Arterial Pressure; Cardiotonic Agents; Disease Models, Animal; Disease Progression; Dobutamine; Energy Metabolism; Heart Failure; Hexokinase; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; L-Lactate Dehydrogenase; Male; Mitochondria, Heart; Monocrotaline; Oxygen; Oxygen Consumption; Protoporphyrins; Pulmonary Artery; Rats, Wistar; Ventricular Dysfunction, Right; Ventricular Function, Right

2015
Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:6

    Topics: Adrenergic beta-1 Receptor Agonists; Animals; Blood Pressure; Cardiac Catheterization; Cardiac Output; Chronic Disease; Disease Models, Animal; Dobutamine; Feasibility Studies; Heart Rate; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Predictive Value of Tests; Time Factors; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Pressure

2010
GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.
    Circulation, 2012, Dec-11, Volume: 126, Issue:24

    Topics: Animals; Cardiotonic Agents; Cells, Cultured; Dobutamine; Dopamine; Down-Regulation; Female; G-Protein-Coupled Receptor Kinase 2; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Myocardial Contraction; Myocytes, Cardiac; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Signal Transduction; Xanthenes

2012